Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank50
3Y CAGR-33.3%
5Y CAGR+166.4%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-33.3%/yr
vs +224.2%/yr prior
5Y CAGR
+166.4%/yr
Recent deceleration
Acceleration
-257.4pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
134.1x
Strong expansion
Streak
3 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.02 | -46.9% |
| 2024 | 0.03 | -21.2% |
| 2023 | 0.04 | -29.1% |
| 2022 | 0.06 | - |
| 2021 | 0.00 | -100.0% |
| 2020 | 0.00 | -71.0% |
| 2019 | 0.00 | -15.6% |
| 2018 | 0.00 | -100.0% |
| 2017 | 7.97 | - |